224 related articles for article (PubMed ID: 12653892)
1. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma.
Kahng YS; Lee YS; Kim BK; Park WS; Lee JY; Kang CS
J Gastroenterol Hepatol; 2003 Apr; 18(4):430-6. PubMed ID: 12653892
[TBL] [Abstract][Full Text] [Related]
2. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.
Maggioni M; Coggi G; Cassani B; Bianchi P; Romagnoli S; Mandelli A; Borzio M; Colombo P; Roncalli M
Hepatology; 2000 Nov; 32(5):942-6. PubMed ID: 11050043
[TBL] [Abstract][Full Text] [Related]
3. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma.
Lu T; Hano H; Meng C; Nagatsuma K; Chiba S; Ikegami M
World J Gastroenterol; 2007 Feb; 13(7):1090-7. PubMed ID: 17373745
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis.
Zhu Q; Gong L; Liu X; Wang J; Ren P; Zhang W; Yao L; Han X; Zhu S; Lan M; Li Y; Zhang W
Diagn Pathol; 2015 Jun; 10():70. PubMed ID: 26076954
[TBL] [Abstract][Full Text] [Related]
6. Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer.
Kurimoto F; Gemma A; Hosoya Y; Seike M; Takenaka K; Uematsu K; Yoshimura A; Shibuya M; Kudoh S
Int J Mol Med; 2001 Jul; 8(1):89-93. PubMed ID: 11408955
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and microsatellite instability in human non-neoplastic hepatic lesions.
Tsopanomichalou M; Kouroumalis E; Ergazaki M; Spandidos DA
Liver; 1999 Aug; 19(4):305-11. PubMed ID: 10459629
[TBL] [Abstract][Full Text] [Related]
8. Frequent allelic imbalances at 8p and 11q22 in oral and oropharyngeal epithelial dysplastic lesions.
Zhou X; Jordan RC; Li Y; Huang BL; Wong DT
Cancer Genet Cytogenet; 2005 Aug; 161(1):86-9. PubMed ID: 16080964
[TBL] [Abstract][Full Text] [Related]
9. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
[TBL] [Abstract][Full Text] [Related]
10. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis.
Kanai Y; Ushijima S; Tsuda H; Sakamoto M; Hirohashi S
Cancer Lett; 2000 Jan; 148(1):73-80. PubMed ID: 10680595
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of the liver putative tumor suppressor (LPTS) gene in hepatocellular carcinomas.
Park WS; Lee JH; Park JY; Jeong SW; Shin MS; Kim HS; Lee SK; Lee SN; Lee SH; Park CG; Yoo NJ; Lee JY
Cancer Lett; 2002 Apr; 178(2):199-207. PubMed ID: 11867205
[TBL] [Abstract][Full Text] [Related]
15. Allelic loss of chromosomal arm 8p in breast cancer progression.
Anbazhagan R; Fujii H; Gabrielson E
Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423
[TBL] [Abstract][Full Text] [Related]
16. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma.
Emi M; Fujiwara Y; Ohata H; Tsuda H; Hirohashi S; Koike M; Miyaki M; Monden M; Nakamura Y
Genes Chromosomes Cancer; 1993 Jul; 7(3):152-7. PubMed ID: 7687868
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.
Kishimoto Y; Shiota G; Wada K; Kitano M; Nakamoto K; Kamisaki Y; Suou T; Itoh T; Kawasaki H
J Cancer Res Clin Oncol; 1996; 122(10):585-9. PubMed ID: 8879255
[TBL] [Abstract][Full Text] [Related]
18. Allelotype analysis of hepatocellular carcinoma.
Piao Z; Park C; Park JH; Kim H
Int J Cancer; 1998 Jan; 75(1):29-33. PubMed ID: 9426686
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis.
Song Z; Li R; You N; Tao K; Dou K
Mol Biol Rep; 2010 Dec; 37(8):4091-101. PubMed ID: 20300861
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis.
Lee YH; Oh BK; Yoo JE; Yoon SM; Choi J; Kim KS; Park YN
Mod Pathol; 2009 Aug; 22(8):1121-31. PubMed ID: 19465904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
